Media Partner

Information for Media Partners

International Journal of Drug Regulatory Affairs (IJDRA) is a broad-based journal giving leading international coverage of all aspects of Pharmaceutical Sciences. It publishes high quality original research & reviews. By advertising in IJDRA, you can reach the targeted audiences worldwide. Your product information disseminates internationally with comparatively low cost budget.

Readership

Regulatory Affairs professionals /Scholars, Patent agents, IPR / F&D / R&D professionals, Pharmacologists; toxicologists; Pharmaceutical researchers; Pharmacists; Clinicians, Analysts, Medical and Health Sciences. etc.

EVENT DETAILS

POSTER

 Advertisement Policy:While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.
This Journal carries an advertisement, which generates income, but journal not be dominated by advertisements, and advertising must not be allowed to influence editorial decisions.Journal follows advertising policies as per International Committee of Medical Journal Editors (ICMJE).
Advertising and Special Services Contact Information:
Dr. Jitendra Badjatya
Editor-In-Chief
Phone: +91-7096160846
Email: editorijdra@gmail.com  

1.         

Company: Virtue Insight

Event:Understanding recent regulatory developments to explore innovative strategies”

Date and venue: 12th March 2020, Kohinoor Continental Hotel, Mumbai, India

Description:India is an attractive target for pharmaceutical companies and other clinical research providers. India promises access to more patients, in greater concentrations, than most other markets, as well as the opportunity to establish trials with treatment-naïve patients. India is a pool of diverse population base of more than 1.2 billion and is a home for a numerous diseases, Institutions and hub of contract manufacturers and researchers. Indian economy stand as the third largest based on the Purchasing Power Parity (PPP) and in terms of globally eleventh largest by nominal Gross Domestic Product (GDP). India is today one of the top emerging markets in the global pharmaceutical scene. The sector is highly knowledge based and its steady growth is positively affecting the Indian economy. The organised nature of the Indian pharmaceutical industry is attracting several companies that are finding it viable to increase their operations in the country. Further, India is home to about 10,500 manufacturing units and over 3,000 pharma companies. India exports all forms of pharmaceuticals from APIs to formulations, both in modern medicine and traditional Indian medicines.

Event website:

https://www.virtueinsight.com/pharma/3rd-Annual-Pharma-Regulatory-Summit-2020/

Email: Kavitha@virtueinsight.co.in; info@virtueinsight.com (T. Kavitha)

Contact: +91 44 24762472

2.         

Company: Meetings International

Event: 3rd World Biomarkers Summit

Date: April 22-23,2020; Venue: Rome, Italy

Description: The 2020 edition of the Biomarkers conference will move forward with the theme "Biomarker as a future protagonist ". Biomarkers 2020 concentrates on procuring emerging researches in the sector of medicine and health brought to us via applications of biomarkers. Scientists, Young researchers, pharmaceutical industrialists, and medical professionals are expected to form global networking through this conference thereby getting and letting explore the topic to a greater extent. This meeting deals with the field of immunology, nutrition, epidemiology, cancer biology, targeted cancer therapies, and cancer pharmacology, etc. Rome has been finalized as the venue for the summit and is full of tourists' attraction places. We welcome participants from all over the globe to join us for the summit as well as to explore the beautiful city.

Event website: https://www.meetingsint.com/conferences/biomarkers

Email: biomarkers@insightsummits.com

Contact: +65 3158 1626 (Esther Bennet)

3.        

Company: ExL Events

Event: 3rd eRegulatory Submissions Summit

Venue: Sonesta Philadelphia Rittenhouse Square, Philadelphia, PA

Description: The 3rd eRegulatory Submissions Summit, taking place July 9-10 in Philadelphia, will cover changes made to the electronic submission processes and protocols for constructing strategies for IDMP, RIM, global and regulatory submissions. This summit will also address regulatory information management experiences and the standards for the identification of medicinal products and best practices for eCTD submission requirements.

Event Website: http://bit.ly/2DrZOnZ

Email: ysheflyand@questex.com

Contact: Yuliya Sheflyand (Marketing Manager)

 

4.

Company: Aspireinsci Pvt. Ltd.

Event:Pharma Colloquium 2020

Venue: September 14-15, 2020, Holiday Inn Toronto International Airport 970 Dixon Road, Rexdale Toronto, Ontario M9W1J9, Canada

Description: Pharma Colloquium welcomes you as our guest to the Toronto during September 14-15, 2020. Pharma Colloquium 2020 incorporates about each stage of information, advancement, innovation and organizing; and has a target of making a worldwide gathering for academicians, specialists and business experts to discuss the soundest issues related to pharma, Biotech and Health Care.

This program provides two days of robust discussions in the field of Clinical Trials, Pharmaceutical Formulations and Drug delivery system, Pharmaceutical GMP, GCP & Regulatory Affairs, Medicinal Plants, Traditional Medicines and Marine Drugs, Medicinal Chemistry & Computer Aided Drug Designing, Pharmacology, Neuropharmacology, Pharma Marketing, Orphan and Rare Disease and more.

Event website: http://aspireinsci.com/about-conference.html

Email:info@aspireinsci.com

Contact: +91 9948634863 ; RC Varma (Marketing Manager)

 

Advertisement Policy:

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

This Journal carries an advertisement, which generates income, but journal not be dominated by advertisements, and advertising must not be allowed to influence editorial decisions.

Journal follows advertising policies as per International Committee of Medical Journal Editors (ICMJE).